查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493221

骨科生物製品市場規模、佔有率和趨勢分析報告：2024-2030 年按產品、應用、最終用途、地區和細分市場進行的預測

Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

骨科生物製劑市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球骨科生物製品市場規模將達93億美元，2024年至2030年複合年成長率為5.5%。

世界各地整形外科手術病例數量的不斷增加正在推動對骨科生物製劑的需求。在美國整形外科學會 (AAOS) 2023 年年會上發表的一項研究表明，骨科醫生將面臨滿足全關節置換術(TJA) 日益成長的需求的挑戰。根據這項研究，為了滿足需求，外科醫生需要每五年將 TJA 病例量增加一倍或將外科醫生數量增加 10%。

隨著對醫療保健進步和患者治療結果的日益關注，世界各國政府正在實施政策和舉措來促進骨科生物製劑的發展。例如，美國整形外科學會 (AAOS) 致力於以透明和科學的方式改善肌肉骨骼護理。 2020年10月，AAOS在其網站上推出了生技藥品儀表板，幫助骨科醫生了解生物製藥治療方法的核准情況。該舉措是 AAOS 生物製品計劃的一部分，該計劃為肌肉骨骼健康界提供循證指導。作為這項工作的一部分，AAOS 董事會還修訂了兩份與生技藥品相關的立場聲明。

全球老年人口的成長預計也將推動整形外科手術的需求。根據《2023年印度老化報告》，印度老年人口正快速成長，10年成長率達41%。到2050年，預計超過20%的印度人口將是老年人。隨著年齡的成長，我們的肌肉和骨骼更有可能出現問題，例如骨質疏鬆症、骨關節炎和骨折。因此，對骨科生物製劑的需求將會增加。

此外，道路事故的增加預計也將補充市場的成長。美國公路交通安全管理局報告稱，2023 年上半年估計有 19,515 人死於車禍。與去年同期的死亡人數 20,190 人相比，減少了約 3.3%。此外，2023 年第一季季和第二季的死亡人數均有所下降。因此，預計受傷人數的增加將增加對骨科生物製劑的需求。

市場上的主要企業正在採取聯盟、供應協議和合作夥伴關係等策略，重點是增強產品形成和覆蓋範圍。例如，2023 年 9 月，HippoFi Inc. 與 Zimmer Biomet Holdings Inc. 合作推出了一種用於骨骼生長的合成生醫材料。該生醫材料預計將於 2024 年由 HippoFi 的生技藥品子公司 PUR Biologics 推出。

生技藥品市場亮點

  • 從產品來看，由於文明病的盛行率不斷增加以及透明質酸療法開發的進步，關節內粘稠補充療法細分市場在 2023 年將佔據最大的銷售佔有率。
  • 從應用來看，由於退化性椎間盤疾病的盛行率不斷上升，脊椎融合手術細分市場在 2023 年將佔據最大的收益佔有率。
  • 按最終用途分類，由於接受外科手術的患者數量增加，醫院部門佔據了最大的收益佔有率。
  • 由於存在多個市場參與者和完善的法律規範，北美在市場上佔據主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章全球骨科生物製品市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 骨科生物製劑：市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析
  • 法律規範

第4章全球骨科生物製品市場區隔分析（依產品），2018-2030

  • 定義和範圍
  • 2023 年及 2030 年產品類型市場佔有率分析
  • 細分儀表板
  • 全球骨科生物製品市場（依產品類型），2018-2030
  • 去礦物質骨基質（DBM）
  • 同種異體移植
  • 骨形成蛋白（BMP）
  • 關節內粘稠補充療法
  • 合成骨替代物
  • 幹細胞療法

第 5 章 2018-2030 年全球骨科生物製品市場區隔分析（按應用）

  • 定義和範圍
  • 2023 年和 2030 年應用市場佔有率分析
  • 細分儀表板
  • 全球骨科生物製品市場（按應用），2018-2030
  • 脊椎融合手術
  • 創傷修復
  • 重組手術

第6章 全球骨科生物製品市場區隔分析（依最終用途），2018-2030 年

  • 定義和範圍
  • 2023 年及 2030 年最終用途市場佔有率分析
  • 細分儀表板
  • 全球骨科生物製品市場（依最終用途），2018-2030 年
  • 醫院
  • 門診設施

第7章全球骨科生物製品市場細分分析（按地區），2018-2030

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場簡介
  • 2023 年及 2030 年骨科生物製劑市場佔有率（按地區）
  • 北美洲
    • 北美骨科生物製品市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲骨科生物製品市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Medtronic Plc
    • DePuy Synthes
    • Zimmer Biomet
    • Stryker Corporation
    • Bioventus LLC
    • Seaspine Holdings Corporation
    • Orthofix, Inc.
    • Globus Medical
    • Arthrex, Inc.
    • Bone Biologics Corp.
Product Code: GVR-1-68038-360-7

Orthobiologics Market Growth & Trends:

The global orthobiologics market size is expected to reach USD 9.3 billion by 2030, registering a CAGR of 5.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing cases of orthopedic surgeries across the globe is driving the demand for orthobiologics. A study presented at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) 2023, revealed that orthopedic surgeons would face a challenge in meeting the increasing demand for total joint arthroplasty (TJA). The study found that to keep up with the demand, surgeons will have to either double their TJA caseload or increase the number of surgeons by 10% every five years.

With an increasing focus on healthcare advancements and patient outcomes, governments worldwide are implementing policies and initiatives to foster the growth of orthobiologics. For instance, the American Academy of Orthopedic Surgeons (AAOS) is committed to improving musculoskeletal care in a transparent and scientific way. In October 2020, the AAOS launched the Biologics Dashboard on their website, which is designed to assist orthopedic surgeons in keeping track of the approval status of biologic-based interventions. This initiative is a part of the AAOS Biologics Initiative, which offers evidence-based guidance to the musculoskeletal health community. As part of this effort, the AAOS Board of Directors also revised two position statements related to biologics.

Increasing geriatric population across the globe is also anticipated to boost the demand for orthopedic surgeries. According to the India Ageing Report 2023, country's elderly population is growing at a rapid pace, with a decadal growth rate of 41%. By 2050, over 20% of India's population will be elderly citizens.As people age, they are more likely to experience issues with their muscles and bones, such as osteoporosis, osteoarthritis, and fractures. This results in a greater need for orthobiologics solutions.

Moreover, increasing cases of road accidents is anticipated to supplement the market growth. According to the National Highway Traffic Safety Administration report, there were an estimated 19,515 deaths in motor vehicle accidents during the first half of 2023. This represents a decrease of about 3.3% compared to the same period in the previous year, which had 20,190 fatalities. The report also shows that fatalities decreased during both the first and second quarters of 2023. Thus, the increasing number of injured populations is expected to increase the demand for orthobiologics.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. For instance, inSeptember 2023, HippoFi Inc. partnered with Zimmer Biomet Holdings Inc. to bring forth a synthetic biomaterial for bone growth. The biomaterial will be launched under HippoFi's biologic subsidiary, PUR Biologics in 2024.

Orthobiologics Market Report Highlights:

  • Based on product, the viscosupplementation segment held the largest revenue share in the market in 2023 owing to the increasing prevalence of lifestyle-related conditions and advances in hyaluronic acid therapy development
  • Based on application, the spinal fusion segment held the largest revenue share in the market in 2023 owing to the rising incidence of degenerative disc disease
  • Based on end-use, the hospitals segment accounted for the largest revenue share due to the growing patient population undergoing surgical procedures
  • North America dominated the market due to the presence of several market players and a well-established regulatory framework

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Orthobiologics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Orthobiologics: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework

Chapter 4. Global Orthobiologics Market Segment Analysis, By Product, 2018 - 2030 (USD Billion)

  • 4.1. Definition and Scope
  • 4.2. Product Type Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Orthobiologics Market, by Product Type, 2018 to 2030
  • 4.5. Demineralized Bone Matrix (DBM)
    • 4.5.1. Demineralized Bone Matrix (DBM) market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Allograft
    • 4.6.1. Allograft market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.7. Bone morphogenetic protein (BMP)
    • 4.7.1. Bone morphogenetic protein (BMP) market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.8. Viscosupplementation
    • 4.8.1. Viscosupplementation market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.9. Synthetic bone substitutes
    • 4.9.1. Synthetic bone substitutes market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.10. Stem cell therapy
    • 4.10.1. Stem cell therapy market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Global Orthobiologics Market Segment Analysis, By Application, 2018 - 2030 (USD Billion)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global orthobiologics Market, by Application, 2018 to 2030
  • 5.5. Spinal Fusion
    • 5.5.1. Spinal fusion market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Trauma repair
    • 5.6.1. Trauma repair market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Reconstructive surgery
    • 5.7.1. Reconstructive surgery market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Global Orthobiologics Market Segment Analysis, By End-use, 2018 - 2030 (USD Billion)

  • 6.1. Definition and Scope
  • 6.2. End-use Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Orthobiologics Market, by end-use, 2018 to 2030
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Outpatient facilities
    • 6.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Global Orthobiologics Market Segment Analysis, By Region, 2018 - 2030 (USD Billion)

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Orthobiologics Market Share by Region, 2023 & 2030
  • 7.5. North America
    • 7.5.1. North America orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.5.3. Canada
      • 7.5.3.1. Canada orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.6. Europe
    • 7.6.1. Europe orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.2. UK
      • 7.6.2.1. UK orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.3. Germany
      • 7.6.3.1. Germany orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.4. France
      • 7.6.4.1. France orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.5. Italy
      • 7.6.5.1. Italy orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.6. Spain
      • 7.6.6.1. Spain orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.7. Norway
      • 7.6.7.1. Norway orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.8. Sweden
      • 7.6.8.1. Sweden orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.9. Denmark
      • 7.6.9.1. Denmark orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.2. China
      • 7.7.2.1. China orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.3. India
      • 7.7.3.1. India orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.4. Australia
      • 7.7.4.1. Australia orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.3. UAE
      • 7.9.3.1. UAE orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait orthobiologics market, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic Plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. DePuy Synthes
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Zimmer Biomet
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bioventus LLC
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Seaspine Holdings Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Orthofix, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Arthrex, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bone Biologics Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 5 Global orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global orthobiologics market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 North America orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 8 North America orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 9 North America orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 10 North America orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 11 U.S. orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 12 U.S. orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 13 U.S. orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 Canada orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 15 Canada orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 16 Canada orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 17 Europe orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 18 Europe orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 19 Europe orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 20 Europe orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 21 Germany orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 22 Germany orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Germany orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 UK orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 25 UK orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 26 UK orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 27 France orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 28 France orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 29 France orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 30 Italy orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 31 Italy orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 32 Italy orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Spain orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Spain orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 35 Spain orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 36 Denmark orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 37 Denmark orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 38 Denmark orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Sweden orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 40 Sweden orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 41 Sweden orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 42 Norway orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 43 Norway orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Norway orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Asia Pacific orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Asia Pacific Orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 47 Asia Pacific orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Asia Pacific orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 China orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 50 China orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 51 China orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 Japan orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 53 Japan orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Japan orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 India orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 56 India orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 57 India orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 58 South Korea orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 59 South Korea orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 60 South Korea orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Australia orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 62 Australia orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 63 Australia orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 64 Thailand orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 65 Thailand Orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 66 Thailand Orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 67 Latin America orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 68 Latin America orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 69 Latin America orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 70 Latin America orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 71 Brazil orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 72 Brazil orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 73 Brazil orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 74 Mexico orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 75 Mexico orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 76 Mexico orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 77 Argentina orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 78 Argentina orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 79 Argentina orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80 MEA orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 81 MEA orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 82 MEA orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 83 MEA orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 84 South Africa orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 85 South Africa orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 86 South Africa orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 90 UAE orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 91 UAE orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 92 UAE orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait orthobiologics market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Orthobiologics market: outlook
  • Fig. 9 Orthobiologics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Orthobiologics market driver impact
  • Fig. 12 Orthobiologics market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Orthobiologics market: Product movement analysis
  • Fig. 16 Orthobiologics market: Product outlook and key takeaways
  • Fig. 17 Demineralized bone matrix (DBM) market estimates and forecast, 2018 - 2030
  • Fig. 18 Allograft estimates and forecast, 2018 - 2030
  • Fig. 19 Bone morphogenetic protein (BMP) estimates and forecast, 2018 - 2030
  • Fig. 20 Viscosupplementation estimates and forecast, 2018 - 2030
  • Fig. 21 Synthetic bone substitutes estimates and forecast, 2018 - 2030
  • Fig. 22 Stem cell therapy estimates and forecast, 2018 - 2030
  • Fig. 23 Orthobiologics Market: Application movement Analysis
  • Fig. 24 Orthobiologics market: Application outlook and key takeaways
  • Fig. 25 Spinal fusion market estimates and forecasts, 2018 - 2030
  • Fig. 26 Trauma repair market estimates and forecasts, 2018 - 2030
  • Fig. 27 Reconstructive surgery market estimates and forecasts, 2018 - 2030
  • Fig. 28 Orthobiologics market: End-use movement analysis
  • Fig. 29 Orthobiologics market: End-use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Outpatient facilities market estimates and forecasts, 2018 - 2030
  • Fig. 32 Global orthobiologics market: Regional movement analysis
  • Fig. 33 Global orthobiologics market: Regional outlook and key takeaways
  • Fig. 34 North America orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Europe orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Key country dynamics
  • Fig. 47 France orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 China orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 India orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Latin America orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 MEA orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis, 2022 - 2023